Morgan Stanley Repare Therapeutics Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Morgan Stanley holds 337 shares of RPTX stock, worth $502. This represents 0.0% of its overall portfolio holdings.

Number of Shares

337

Previous 193,515 99.83%

Holding current value

$502

Previous $253,000 100.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.99 - $1.39 $191,246 - $268,517	-193,178 Reduced 99.83%	337 $0
Q4 2024 Feb 14, 2025	SELL	$1.25 - $3.97 $4,165 - $13,228	-3,332 Reduced 1.69%	193,515 $253,000
Q3 2024 May 14, 2025	SELL	$2.75 - $3.99 $272,010 - $394,662	-98,913 Reduced 33.44%	196,847 $677,000
Q3 2024 Nov 14, 2024	SELL	$2.75 - $3.99 $272,010 - $394,662	-98,913 Reduced 33.44%	196,847 $677,000
Q2 2024 May 14, 2025	BUY	$3.02 - $4.7 $308,779 - $480,551	102,245 Added 52.84%	295,760 $976,000
Q2 2024 Oct 17, 2024	BUY	$3.02 - $4.7 $24,857 - $38,685	8,231 Added 2.86%	295,760 $976,000
Q2 2024 Aug 14, 2024	BUY	$3.02 - $4.7 $24,857 - $38,685	8,231 Added 2.86%	295,760 $976,000
Q1 2024 Oct 17, 2024	SELL	$4.53 - $8.41 $37,286 - $69,222	-8,231 Reduced 2.78%	287,529 $1.35 Million
Q1 2024 Aug 16, 2024	SELL	$4.53 - $8.41 $207,156 - $384,589	-45,730 Reduced 13.72%	287,529 $1.35 Million
Q1 2024 May 15, 2024	SELL	$4.53 - $8.41 $207,156 - $384,589	-45,730 Reduced 13.72%	287,529 $1.35 Million
Q4 2023 Aug 16, 2024	BUY	$3.22 - $11.79 $120,746 - $442,113	37,499 Added 12.68%	333,259 $2.43 Million
Q4 2023 Feb 13, 2024	BUY	$3.22 - $11.79 $911,057 - $3.34 Million	282,937 Added 562.25%	333,259 $2.43 Million
Q3 2023 Nov 15, 2023	BUY	$8.16 - $13.01 $8,306 - $13,244	1,018 Added 2.06%	50,322 $607,000
Q2 2023 Aug 14, 2023	SELL	$8.63 - $12.53 $117,359 - $170,395	-13,599 Reduced 21.62%	49,304 $521,000
Q1 2023 May 15, 2023	SELL	$9.32 - $15.06 $121,942 - $197,045	-13,084 Reduced 17.22%	62,903 $618,000
Q4 2022 Feb 14, 2023	SELL	$12.5 - $18.13 $890,875 - $1.29 Million	-71,270 Reduced 48.4%	75,987 $1.12 Million
Q3 2022 Nov 14, 2022	SELL	$11.57 - $15.59 $5,021 - $6,766	-434 Reduced 0.29%	147,257 $1.79 Million
Q2 2022 Oct 27, 2022	BUY	$8.45 - $14.84 $546,799 - $960,296	64,710 Added 77.98%	147,691 $2.07 Million
Q2 2022 Aug 15, 2022	BUY	$8.45 - $14.84 $546,799 - $960,296	64,710 Added 77.98%	147,691 $2.07 Million
Q1 2022 Oct 27, 2022	SELL	$11.38 - $21.88 $736,399 - $1.42 Million	-64,710 Reduced 43.81%	82,981 $1.18 Million
Q1 2022 May 13, 2022	BUY	$11.38 - $21.88 $547,275 - $1.05 Million	48,091 Added 137.84%	82,981 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$19.66 - $28.11 $1.03 Million - $1.47 Million	-52,462 Reduced 60.06%	34,890 $736,000
Q3 2021 Nov 15, 2021	BUY	$25.71 - $35.24 $2.25 Million - $3.08 Million	87,352 New	87,352 $2.29 Million

Others Institutions Holding RPTX

# of Institutions

Shares Held

32.5M

Call Options Held

50K

Put Options Held

900

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $62.5M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account